Investment in R&D by biotech companies grows by 17% to 1,218 million euros 12/06/2024 Healthcare Agrifood Industrial biotechnology Private funding raised by the sector reached an all-time high, surpassing 228 million euros after a 37% increase. AseBio
La biotecnología revoluciona la detección temprana del cáncer de próstata, cuya incidencia... 11/06/2024 Salud Acceso a la innovación Digitalización La biotecnología es fundamental en el diagnóstico, tratamiento y seguimiento del cáncer de próstata y desempeña un... AseBio
Biotechnology and bio-manufacturing win 350 million euros in support and investment from E... 07/06/2024 Digitalization The European Commission thus reinforces biotechnology as central to Europe's green, digital and long-term industrial... AseBio
Biotechnology: key to addressing the triple environmental crisis and achieving the Sustain... 05/06/2024 Climate change Bioeconomy Circular economy Biotechnology addresses environmental challenges through bioremediation, the production of renewable energy, sustainable... AseBio
Collaboration, efficient management of intellectual property and creation of spin-offs, vi... 29/05/2024 Healthcare Access to innovation AseBio has organized, within the framework of the XVII Annual Conference of Biomedical Research Technology Platforms... AseBio
Four AseBio partners will participate in the first IPCEI in the health sector that will mo... 29/05/2024 Healthcare Access to innovation Financing The Major Project of Common European Interest 'Med4Cure' will enable member states to support a total of 14 projects... AseBio
Las innovaciones biotecnológicas, claves en la lucha contra el hambre y el futuro de la in... 28/05/2024 Cambio climático Agroalimentación Food & feed Agricultura Salud animal Con motivo del Día Mundial del Hambre analizamos, a través de nuestros socios AINIA y Tebrio, cómo la biotecnología está... AseBio
#NewAseBioMember | “AseBio is a pivotal networking platform for companies in the biotechno... 23/05/2024 Healthcare Corporate Meet KeyZell, our new member. We talked to its José del Corral, CEO. AseBio
#NewAseBioMember | “This partnership gives us the possibility to establish key contacts an... 20/05/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Meet Kirsch Pharma, our new member. We talked to its Raquel Márquez Duro, Key Account Mánager de España y Portugal. AseBio - Kirsch Pharma España
Biotechnology revolutionizes advances against obesity: enhanced understanding, more accura... 18/05/2024 Healthcare Access to innovation To address how biotechnology is enabling progress in combating obesity from various perspectives, and in celebration of... AseBio
